ReWalk Robotics (NASDAQ:LFWD) Coverage Initiated at Laidlaw

Laidlaw assumed coverage on shares of ReWalk Robotics (NASDAQ:LFWD) in a research note issued on Monday, MarketBeat reports. The brokerage set a “buy” rating and a $10.00 price target on the stock. Laidlaw’s price objective would indicate a potential upside of 346.43% from the company’s current price.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $13.00 price objective on shares of ReWalk Robotics in a research report on Wednesday, November 13th.

ReWalk Robotics Price Performance

Shares of NASDAQ:LFWD opened at $2.24 on Monday. The firm has a market capitalization of $19.73 million, a PE ratio of -0.90 and a beta of 2.05. ReWalk Robotics has a 1 year low of $1.25 and a 1 year high of $7.70. The firm’s 50-day moving average is $1.71 and its two-hundred day moving average is $2.52.

ReWalk Robotics (NASDAQ:LFWD) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.08). The business had revenue of $6.13 million during the quarter, compared to analyst estimates of $8.38 million. ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. During the same quarter last year, the firm earned ($0.56) EPS. Analysts expect that ReWalk Robotics will post -1.78 EPS for the current fiscal year.

Insider Buying and Selling

In other ReWalk Robotics news, Director Michael Swinford acquired 16,471 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average cost of $1.84 per share, for a total transaction of $30,306.64. Following the transaction, the director now directly owns 26,511 shares of the company’s stock, valued at approximately $48,780.24. This represents a 164.05 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Global Fund Lp Lind II sold 381,676 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the sale, the insider now owns 1,049,430 shares in the company, valued at $3,526,084.80. This represents a 26.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders bought 61,000 shares of company stock valued at $115,279 over the last ninety days. Corporate insiders own 2.50% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ReWalk Robotics stock. Dimensional Fund Advisors LP bought a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned 0.16% of ReWalk Robotics as of its most recent filing with the Securities & Exchange Commission. 26.76% of the stock is owned by institutional investors and hedge funds.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.